RL29_HUMAN - dbPTM
RL29_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RL29_HUMAN
UniProt AC P47914
Protein Name 60S ribosomal protein L29
Gene Name RPL29
Organism Homo sapiens (Human).
Sequence Length 159
Subcellular Localization
Protein Description Component of the large ribosomal subunit..
Protein Sequence MAKSKNHTTHNQSRKWHRNGIKKPRSQRYESLKGVDPKFLRNMRFAKKHNKKGLKKMQANNAKAMSARAEAIKALVKPKEVKPKIPKGVSRKLDRLAYIAHPKLGKRARARIAKGLRLCRPKAKAKAKAKDQTKAQAAAPASVPAQAPKRTQAPTKASE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Ubiquitination-----MAKSKNHTTH
-----CCCCCCCCCC
61.7424816145
4O-linked_Glycosylation----MAKSKNHTTHN
----CCCCCCCCCCH
29.2028510447
5Methylation---MAKSKNHTTHNQ
---CCCCCCCCCCHH
52.6312962325
8PhosphorylationMAKSKNHTTHNQSRK
CCCCCCCCCCHHHHH
38.8628152594
9PhosphorylationAKSKNHTTHNQSRKW
CCCCCCCCCHHHHHH
15.9828152594
13O-linked_GlycosylationNHTTHNQSRKWHRNG
CCCCCHHHHHHHHCC
40.9428510447
23UbiquitinationWHRNGIKKPRSQRYE
HHHCCCCCCHHHHHH
43.6824816145
26PhosphorylationNGIKKPRSQRYESLK
CCCCCCHHHHHHHHC
27.7728152594
29PhosphorylationKKPRSQRYESLKGVD
CCCHHHHHHHHCCCC
11.3928152594
31PhosphorylationPRSQRYESLKGVDPK
CHHHHHHHHCCCCHH
26.8423401153
33AcetylationSQRYESLKGVDPKFL
HHHHHHHCCCCHHHH
67.1919608861
33UbiquitinationSQRYESLKGVDPKFL
HHHHHHHCCCCHHHH
67.1923000965
33UbiquitinationSQRYESLKGVDPKFL
HHHHHHHCCCCHHHH
67.1921890473
38UbiquitinationSLKGVDPKFLRNMRF
HHCCCCHHHHHHHHH
53.2023000965
38UbiquitinationSLKGVDPKFLRNMRF
HHCCCCHHHHHHHHH
53.2021890473
38AcetylationSLKGVDPKFLRNMRF
HHCCCCHHHHHHHHH
53.2025953088
56UbiquitinationHNKKGLKKMQANNAK
HCHHHHHHHHHHHHH
41.0921906983
63UbiquitinationKMQANNAKAMSARAE
HHHHHHHHHHHHHHH
46.9023000965
63AcetylationKMQANNAKAMSARAE
HHHHHHHHHHHHHHH
46.9025953088
66PhosphorylationANNAKAMSARAEAIK
HHHHHHHHHHHHHHH
21.3322199227
73UbiquitinationSARAEAIKALVKPKE
HHHHHHHHHHHCCHH
42.5921890473
73AcetylationSARAEAIKALVKPKE
HHHHHHHHHHHCCHH
42.5925953088
73UbiquitinationSARAEAIKALVKPKE
HHHHHHHHHHHCCHH
42.5923000965
77AcetylationEAIKALVKPKEVKPK
HHHHHHHCCHHCCCC
51.7426051181
77UbiquitinationEAIKALVKPKEVKPK
HHHHHHHCCHHCCCC
51.7423000965
79UbiquitinationIKALVKPKEVKPKIP
HHHHHCCHHCCCCCC
70.2223000965
82UbiquitinationLVKPKEVKPKIPKGV
HHCCHHCCCCCCCCH
41.5024816145
82AcetylationLVKPKEVKPKIPKGV
HHCCHHCCCCCCCCH
41.5019608861
84UbiquitinationKPKEVKPKIPKGVSR
CCHHCCCCCCCCHHH
66.96-
90PhosphorylationPKIPKGVSRKLDRLA
CCCCCCHHHHHHHHH
32.1627282143
95MethylationGVSRKLDRLAYIAHP
CHHHHHHHHHHHHCH
31.49115492009
98PhosphorylationRKLDRLAYIAHPKLG
HHHHHHHHHHCHHCC
11.8422461510
103UbiquitinationLAYIAHPKLGKRARA
HHHHHCHHCCHHHHH
61.0621890473
103AcetylationLAYIAHPKLGKRARA
HHHHHCHHCCHHHHH
61.0623236377
103UbiquitinationLAYIAHPKLGKRARA
HHHHHCHHCCHHHHH
61.0621906983
106UbiquitinationIAHPKLGKRARARIA
HHCHHCCHHHHHHHH
54.01-
114UbiquitinationRARARIAKGLRLCRP
HHHHHHHHHHHHHCH
56.9927667366
114MethylationRARARIAKGLRLCRP
HHHHHHHHHHHHHCH
56.9972620571
119S-palmitoylationIAKGLRLCRPKAKAK
HHHHHHHHCHHHHHH
5.9029575903
1222-HydroxyisobutyrylationGLRLCRPKAKAKAKA
HHHHHCHHHHHHHHH
43.07-
128UbiquitinationPKAKAKAKAKDQTKA
HHHHHHHHHHHHHHH
56.0923503661
130AcetylationAKAKAKAKDQTKAQA
HHHHHHHHHHHHHHH
50.0626051181
130UbiquitinationAKAKAKAKDQTKAQA
HHHHHHHHHHHHHHH
50.0622817900
134AcetylationAKAKDQTKAQAAAPA
HHHHHHHHHHHHCCC
32.6323236377
134UbiquitinationAKAKDQTKAQAAAPA
HHHHHHHHHHHHCCC
32.6321906983
142O-linked_GlycosylationAQAAAPASVPAQAPK
HHHHCCCCCCCCCCC
27.8128510447
142PhosphorylationAQAAAPASVPAQAPK
HHHHCCCCCCCCCCC
27.8130266825
149AcetylationSVPAQAPKRTQAPTK
CCCCCCCCCCCCCCC
71.7126051181
1492-HydroxyisobutyrylationSVPAQAPKRTQAPTK
CCCCCCCCCCCCCCC
71.71-
149UbiquitinationSVPAQAPKRTQAPTK
CCCCCCCCCCCCCCC
71.7123000965
149MethylationSVPAQAPKRTQAPTK
CCCCCCCCCCCCCCC
71.7124506953
151O-linked_GlycosylationPAQAPKRTQAPTKAS
CCCCCCCCCCCCCCC
34.9028510447
151PhosphorylationPAQAPKRTQAPTKAS
CCCCCCCCCCCCCCC
34.9024732914
155PhosphorylationPKRTQAPTKASE---
CCCCCCCCCCCC---
42.1124732914
156UbiquitinationKRTQAPTKASE----
CCCCCCCCCCC----
49.1833845483
158PhosphorylationTQAPTKASE------
CCCCCCCCC------
45.4528355574

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RL29_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RL29_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RL29_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SYBU_HUMANSYBUphysical
16169070
CHD3_HUMANCHD3physical
16169070
RL6_HUMANRPL6physical
22939629
RL5_HUMANRPL5physical
22939629
RL8_HUMANRPL8physical
22939629
RL9_HUMANRPL9physical
22939629
RS15A_HUMANRPS15Aphysical
22939629
RS23_HUMANRPS23physical
22939629
RS26_HUMANRPS26physical
22939629
RSSA_HUMANRPSAphysical
22939629
RS3_HUMANRPS3physical
22939629
RL4_HUMANRPL4physical
22939629
RS12_HUMANRPS12physical
22939629
RS6_HUMANRPS6physical
22939629
RS3A_HUMANRPS3Aphysical
22939629
RS16_HUMANRPS16physical
22939629
RS20_HUMANRPS20physical
22939629
RS2_HUMANRPS2physical
22939629
RL7A_HUMANRPL7Aphysical
22939629
RS24_HUMANRPS24physical
22939629
RL32_HUMANRPL32physical
22939629
RL38_HUMANRPL38physical
22939629
IL7RA_HUMANIL7Rphysical
23151878
PRS8_HUMANPSMC5physical
22863883
RL9_HUMANRPL9physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RL29_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-33 AND LYS-82, AND MASSSPECTROMETRY.
Methylation
ReferencePubMed
"Characterization and analysis of posttranslational modifications ofthe human large cytoplasmic ribosomal subunit proteins by massspectrometry and Edman sequencing.";
Odintsova T.I., Muller E.C., Ivanov A.V., Egorov T.A., Bienert R.,Vladimirov S.N., Kostka S., Otto A., Wittmann-Liebold B.,Karpova G.G.;
J. Protein Chem. 22:249-258(2003).
Cited for: PROTEIN SEQUENCE OF 2-15, MASS SPECTROMETRY, AND METHYLATION AT LYS-5.
Phosphorylation
ReferencePubMed
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY.
Ubiquitylation
ReferencePubMed
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry.";
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
Proteomics 7:868-874(2007).
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-56 AND LYS-73, AND MASSSPECTROMETRY.

TOP